Canada markets open in 7 hours 22 minutes

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.97-0.24 (-3.33%)
At close: 04:00PM EDT
6.90 -0.07 (-1.00%)
After hours: 05:08PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.37M
Enterprise Value 178.21k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.24k
Price/Book (mrq)0.96
Enterprise Value/Revenue 178.21
Enterprise Value/EBITDA -0.02

Trading Information

Stock Price History

Beta (5Y Monthly) 1.35
52-Week Change 3-55.89%
S&P500 52-Week Change 322.64%
52 Week High 316.60
52 Week Low 35.00
50-Day Moving Average 37.31
200-Day Moving Average 38.18

Share Statistics

Avg Vol (3 month) 310.85k
Avg Vol (10 day) 32.72k
Shares Outstanding 5914.23k
Implied Shares Outstanding 6914.23k
Float 8699.98k
% Held by Insiders 145.47%
% Held by Institutions 15.52%
Shares Short (Apr 15, 2024) 410.18k
Short Ratio (Apr 15, 2024) 40.67
Short % of Float (Apr 15, 2024) 41.37%
Short % of Shares Outstanding (Apr 15, 2024) 41.11%
Shares Short (prior month Mar 15, 2024) 412.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 09, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,954.89%

Management Effectiveness

Return on Assets (ttm)-74.90%
Return on Equity (ttm)-139.14%

Income Statement

Revenue (ttm)184k
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -7.17M
Net Income Avi to Common (ttm)-5.57M
Diluted EPS (ttm)-7.41
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.76M
Total Cash Per Share (mrq)7.39
Total Debt (mrq)565k
Total Debt/Equity (mrq)8.51%
Current Ratio (mrq)5.55
Book Value Per Share (mrq)8.50

Cash Flow Statement

Operating Cash Flow (ttm)-7.09M
Levered Free Cash Flow (ttm)-5.65M